JBM (Healthcare) Limited

SEHK:2161 Stock Report

Market Cap: HK$2.7b

JBM (Healthcare) (2161) Stock Overview

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. More details

2161 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance5/6
Financial Health6/6
Dividends2/6

Rewards

Trading at 61.2% below our estimate of its fair value

Earnings are forecast to grow 15.93% per year

Earnings grew by 51.2% over the past year

Risk Analysis

No risks detected for 2161 from our risk checks.

2161 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

JBM (Healthcare) Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for JBM (Healthcare)
Historical stock prices
Current Share PriceHK$3.35
52 Week HighHK$3.36
52 Week LowHK$0.86
Beta0.29
1 Month Change31.37%
3 Month Change88.20%
1 Year Change222.12%
3 Year Change318.75%
5 Year Changen/a
Change since IPO55.09%

Recent News & Updates

The Market Lifts JBM (Healthcare) Limited (HKG:2161) Shares 38% But It Can Do More

Jun 18
The Market Lifts JBM (Healthcare) Limited (HKG:2161) Shares 38% But It Can Do More

JBM (Healthcare) Limited Just Recorded A 20% EPS Beat: Here's What Analysts Are Forecasting Next

Jun 15
JBM (Healthcare) Limited Just Recorded A 20% EPS Beat: Here's What Analysts Are Forecasting Next

Recent updates

The Market Lifts JBM (Healthcare) Limited (HKG:2161) Shares 38% But It Can Do More

Jun 18
The Market Lifts JBM (Healthcare) Limited (HKG:2161) Shares 38% But It Can Do More

JBM (Healthcare) Limited Just Recorded A 20% EPS Beat: Here's What Analysts Are Forecasting Next

Jun 15
JBM (Healthcare) Limited Just Recorded A 20% EPS Beat: Here's What Analysts Are Forecasting Next

There's Reason For Concern Over JBM (Healthcare) Limited's (HKG:2161) Massive 28% Price Jump

May 04
There's Reason For Concern Over JBM (Healthcare) Limited's (HKG:2161) Massive 28% Price Jump

JBM (Healthcare) Limited (HKG:2161) Stock Rockets 35% But Many Are Still Ignoring The Company

Nov 08
JBM (Healthcare) Limited (HKG:2161) Stock Rockets 35% But Many Are Still Ignoring The Company

JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Dec 20
JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

Nov 01
Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Jul 29
JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Aug 03
Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Jul 28
Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Shareholder Returns

2161HK PharmaceuticalsHK Market
7D6.3%1.7%1.0%
1Y222.1%50.3%25.8%

Return vs Industry: 2161 exceeded the Hong Kong Pharmaceuticals industry which returned 50.3% over the past year.

Return vs Market: 2161 exceeded the Hong Kong Market which returned 25.8% over the past year.

Price Volatility

Is 2161's price volatile compared to industry and market?
2161 volatility
2161 Average Weekly Movement8.9%
Pharmaceuticals Industry Average Movement8.6%
Market Average Movement7.8%
10% most volatile stocks in HK Market15.3%
10% least volatile stocks in HK Market4.2%

Stable Share Price: 2161 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 2161's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2020279Patrick Wongwww.jbmhealthcare.com.hk

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients.

JBM (Healthcare) Limited Fundamentals Summary

How do JBM (Healthcare)'s earnings and revenue compare to its market cap?
2161 fundamental statistics
Market capHK$2.73b
Earnings (TTM)HK$197.26m
Revenue (TTM)HK$782.29m
13.8x
P/E Ratio
3.5x
P/S Ratio

Is 2161 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2161 income statement (TTM)
RevenueHK$782.29m
Cost of RevenueHK$368.59m
Gross ProfitHK$413.71m
Other ExpensesHK$216.45m
EarningsHK$197.26m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.24
Gross Margin52.88%
Net Profit Margin25.22%
Debt/Equity Ratio12.9%

How did 2161 perform over the long term?

See historical performance and comparison

Dividends

6.9%
Current Dividend Yield
71%
Payout Ratio

Does 2161 pay a reliable dividends?

See 2161 dividend history and benchmarks
When do you need to buy 2161 by to receive an upcoming dividend?
JBM (Healthcare) dividend dates
Ex Dividend DateAug 11 2025
Dividend Pay DateAug 28 2025
Days until Ex dividend40 days
Days until Dividend pay date57 days

Does 2161 pay a reliable dividends?

See 2161 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/01 19:23
End of Day Share Price 2025/06/30 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

JBM (Healthcare) Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mun Hon ThamUOB Kay Hian Research Pte Ltd
Sunny ChenUOB Kay Hian Research Pte Ltd
Kate LuangUOB Kay Hian Research Pte Ltd